Susquehanna International Group’s Invesco Pharmaceuticals ETF PJP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-2,800
| Closed | -$224K | – | 13553 |
|
|
2025
Q2 | $224K | Buy |
+2,800
| New | +$223K | ﹤0.01% | 10980 |
|
|
2023
Q3 | – | Sell |
-3,200
| Closed | -$242K | – | 12735 |
|
|
2023
Q2 | $242K | Buy |
+3,200
| New | +$244K | ﹤0.01% | 9878 |
|
|
2023
Q1 | – | Sell |
-4,800
| Closed | -$377K | – | 13261 |
|
|
2022
Q4 | $377K | Buy |
4,800
+1,700
| +55% | +$131K | ﹤0.01% | 8543 |
|
|
2022
Q3 | $221K | Buy |
+3,100
| New | +$231K | ﹤0.01% | 10580 |
|
|
2021
Q3 | – | Sell |
-4,000
| Closed | -$322K | – | 13359 |
|
|
2021
Q2 | $322K | Sell |
4,000
-28,400
| -88% | -$2.26M | ﹤0.01% | 10621 |
|
|
2021
Q1 | $2.56M | Buy |
+32,400
| New | +$2.53M | ﹤0.01% | 5328 |
|
|
2020
Q1 | – | Sell |
-6,900
| Closed | -$447K | – | 10731 |
|
|
2019
Q4 | $447K | Buy |
+6,900
| New | +$420K | ﹤0.01% | 7209 |
|
|
2019
Q1 | – | Sell |
-4,100
| Closed | -$256K | – | 9604 |
|
|
2018
Q4 | $256K | Buy |
4,100
+300
| +8% | +$20.2K | ﹤0.01% | 7291 |
|
|
2018
Q3 | $279K | Buy |
+3,800
| New | +$273K | ﹤0.01% | 7621 |
|
|
2018
Q2 | – | Sell |
-17,000
| Closed | -$1.06M | – | 10204 |
|
|
2018
Q1 | $1.06M | Buy |
17,000
+1,400
| +9% | +$92.2K | ﹤0.01% | 5113 |
|
|
2017
Q4 | $1M | Sell |
15,600
-9,400
| -38% | -$603K | ﹤0.01% | 5229 |
|
|
2017
Q3 | $1.63M | Sell |
25,000
-1,900
| -7% | -$120K | ﹤0.01% | 4296 |
|
|
2017
Q2 | $1.69M | Buy |
26,900
+16,500
| +159% | +$990K | ﹤0.01% | 4223 |
|
|
2017
Q1 | $611K | Buy |
10,400
+6,100
| +142% | +$357K | ﹤0.01% | 6127 |
|
|
2016
Q4 | $241K | Sell |
4,300
-4,100
| -49% | -$236K | ﹤0.01% | 8361 |
|
|
2016
Q3 | $518K | Sell |
8,400
-2,500
| -23% | -$164K | ﹤0.01% | 5993 |
|
|
2016
Q2 | $691K | Sell |
10,900
-11,200
| -51% | -$704K | ﹤0.01% | 5549 |
|
|
2016
Q1 | $1.33M | Buy |
22,100
+13,900
| +170% | +$850K | ﹤0.01% | 4517 |
|
|
2015
Q4 | $574K | Sell |
8,200
-5,400
| -40% | -$383K | ﹤0.01% | 6505 |
|
|
2015
Q3 | $902K | Sell |
13,600
-8,600
| -39% | -$669K | ﹤0.01% | 5971 |
|
|
2015
Q2 | $1.74M | Buy |
22,200
+1,500
| +7% | +$117K | ﹤0.01% | 5015 |
|
|
2015
Q1 | $1.58M | Sell |
20,700
-13,400
| -39% | -$985K | ﹤0.01% | 4789 |
|
|
2014
Q4 | $2.27M | Buy |
34,100
+17,700
| +108% | +$1.18M | ﹤0.01% | 4213 |
|
|
2014
Q3 | $1.04M | Buy |
16,400
+8,400
| +105% | +$519K | ﹤0.01% | 5830 |
|
|
2014
Q2 | $489K | Buy |
+8,000
| New | +$464K | ﹤0.01% | 7524 |
|
Other funds holding PJP
PAM
CI
Susquehanna International Group's PJP Position: Q3 2025 in Review
Susquehanna International Group sold out of Invesco Pharmaceuticals ETF (PJP) in Q3 2025, closing a stake of 6,825 shares — an estimated $545K sold.
Susquehanna International Group first reported a position in PJP in Q2 2013 and held it in 43 quarters. The position peaked at $4.8M in Q1 2016. 93 funds tracked by Wall St. Rank hold PJP as of Q3 2025.
- Susquehanna International Group reported no remaining Invesco Pharmaceuticals ETF position as of Q3 2025 after selling out during the quarter.
- Susquehanna International Group sold 6,825 Invesco Pharmaceuticals ETF shares in Q3 2025, an estimated $545K.
- Susquehanna International Group first reported a position in Invesco Pharmaceuticals ETF in Q2 2013 and held it in 43 quarters.
- Susquehanna International Group's Invesco Pharmaceuticals ETF position peaked at $4.8M in Q1 2016.
- 93 funds tracked by Wall St. Rank held Invesco Pharmaceuticals ETF as of Q3 2025.
Based on Susquehanna International Group's 13F filing for Q3 2025, filed 14 Nov 2025.